Elegen

Full-Stack Developer

Remote

$60,000 – $90,000Compensation
Junior (1 to 2 years), Entry Level & New GradExperience Level
InternshipJob Type
UnknownVisa
Software DevelopmentIndustries

Requirements

Candidates should possess at least 2 years of hands-on experience building web applications from the ground up, demonstrating proficiency in React and TailwindCSS, along with solid backend skills in Node.js (Express or similar) and experience working with PostgreSQL or a comparable relational database. A strong understanding of API integration, authentication flows, and data modeling is also required, complemented by a commitment to clean, maintainable coding style and Git proficiency.

Responsibilities

The Full-Stack Developer will be responsible for developing a custom internal platform from scratch using React and Node.js, collaborating directly with design and sales teams to implement user flows and key features, owning the full development cycle including planning, architecture, deployment, and maintenance, and proactively proposing improvements and shaping product decisions alongside the founder. They will also be responsible for driving features from idea to release and ensuring a seamless integration of the platform into the company's workflows.

Skills

React
TailwindCSS
Node.js
Express
PostgreSQL
API Integration
Authentication
Data Modeling
Git

Elegen

Custom DNA synthesis for biotech applications

About Elegen

Elegen focuses on improving the process of manufacturing synthetic DNA to meet the needs of the bioeconomy. The company provides custom DNA synthesis services to researchers, biotech companies, and pharmaceutical firms that require high-quality and complex synthetic DNA for various applications, including biomanufacturing and mRNA-based treatments. Elegen uses advanced technologies to ensure fast turnaround times and high accuracy in DNA synthesis, which are essential for its clients' projects. Unlike its competitors, Elegen not only streamlines traditional DNA manufacturing workflows but also enables the production of valuable biologics and therapeutics. The company's goal is to support the development of next-generation mRNA medicines and other advanced therapeutics by providing reliable and efficient DNA solutions.

Key Metrics

San Carlos, CaliforniaHeadquarters
2017Year Founded
$34MTotal Funding
SERIES_BCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Unlimited Paid Time Off
Short Term Disability
Long Term Disability
Parental Leave
Commuter Benefits
Fitness Allowance
Learning Allowance

Risks

Increased competition from companies like Twist Bioscience in DNA synthesis capabilities.
Potential intellectual property disputes could impact Elegen's proprietary technologies.
Dependence on key partnerships, like GSK, could affect market position if dissolved.

Differentiation

Elegen's ENFINIA™ DNA offers rapid synthesis of highly complex DNA in 10 days.
The company provides cell-free DNA production, reducing contamination risks and improving efficiency.
Elegen's Early Access Program allows clients early access to high-complexity DNA breakthroughs.

Upsides

Elegen raised $35M to expand its ENFINIA™ DNA product line for clinical development.
Collaboration with GSK enhances Elegen's cell-free DNA technology for vaccines and medicines.
Elegen's ability to synthesize complex DNA sequences gives it a competitive market edge.

Land your dream remote job 3x faster with AI